1. Chronic Kidney Disease in Long-Term Survivors after Allogeneic Hematopoietic Stem Cell Transplantation: Retrospective Analysis at a Single Institute 
Tomoyasu Jo, Yasuyuki Arai, Tadakazu Kondo, Toshiyuki Kitano, Masakatsu Hishizawa, Kouhei Yamashita, Akifumi Takaori-Kondo 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 12, Pages (December 2017)
DOI: /j.bbmt
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence and prevalence of CKD after allo-HSCT. (A) The Gray's curve shows that the incidence of CKD increased with time and reached 25.1% at 10 years after allo-HSCT. (B) Prevalence of CKD at 5 years after allo-HSCT according to age groups. The prevalence rate of CKD increased with age and increased to 34.8% in patients who were 60 years of age or older.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Change over time in eGFR before and after allo-HSCT (A) in all patients and (B) in patients with CKD (solid line) and without CKD (dotted line). The vertical lines represent ±1 standard deviation above the mean.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3 Effect of CKD on OS after allo-HSCT.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2017 The American Society for Blood and Marrow Transplantation Terms and Conditions